Cleared Traditional

K092153 - SKYLINE 55

K092153 is an FDA 510(k) clearance for SKYLINE 55, manufactured by Larsen & Toubro Limited. The device is a Class 2 Cardiovascular device with product code MWI cleared through the Traditional 510(k) pathway after a 127-day FDA review.

K092153 · Larsen & Toubro Limited · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2009
Decision
127d
Days
Class 2
Risk

K092153 is an FDA 510(k) clearance for the SKYLINE 55, MODEL VER 1. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Larsen & Toubro Limited (Schaumburg, US). The FDA issued a Cleared decision on November 20, 2009 after a review of 127 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Larsen & Toubro Limited devices

FDA 510(k) Submission Details - K092153

510(k) Number K092153 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 16, 2009
Decision Date November 20, 2009
Days to Decision 127 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
2d slower than avg
Panel avg: 125d · This submission: 127d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MWI Device Classification - Class 2, Special Controls

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 174
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K092153.
VITAL SIGNS MONITOR-VSM 6000 SERIES
K101445 · Welch Allyn, Inc. · Jun 2010
STELLAR 300
K093017 · Larsen & Toubro Limited · Apr 2010
INTELLIBRIDGE SYSTEM
K093177 · Philips Medical Systems · Dec 2009
VITAL SIGNS MONITOR, MODEL: MD500B
K082787 · Beijing Choice Electronic Technololgy Co., Ltd. · Jan 2009
OMRON MODEL HBP-2070 VITAL SIGNS MONITOR
K082812 · Omron Healthcare, Inc. · Oct 2008
GALAXY 55
K082685 · Larsen & Toubro Limited · Sep 2008